Conduent

Overview

Conduent is a BPO-heritage hub-services and PAP-administration operator (NASDAQ: CNDT) that runs patient access, copay administration, prior authorization, and Medicaid pharmacy claims for 7 of the top 10 pharma manufacturers on its IntelliHealth cloud platform. The company was spun off from Xerox in January 2017 and operates 100+ global locations with 20+ language support.

Conduent is not a purpose-built specialty hub or a digital-first DTP platform. The pharma footprint is rooted in high-volume PAP administration, transactional copay processing, and federally certified Medicaid PBM operations (Flexible Rx System, 454M+ claims/year). Parent-level financial distress and ongoing divestitures (BenefitWallet HSA portfolio to HealthEquity for $425M in May 2024) make the corporate trajectory a diligence input — confirm pharma-segment commitments and roadmap during the RFP.

Hub Capability Model

The framework below standardizes how Rx Almanac evaluates hub-services capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, Conduent is evaluated as a BPO-heritage PAP and hub-operations platform.

Capability	Buyer should compare	Conduent readout
Therapy initiation and enrollment intake	Digital and human intake, eConsent, missing-information resolution, provider/patient portals, and clean case creation.	Intake workflow. Services include eBenefits Investigation, eConsent (text, email, and agent-derived validation), and Patient Coverage Check; confirm provider-portal depth and missing-info resolution latency in RFP.
Benefits verification and coverage triage	Medical/pharmacy benefit verification, eligibility checks, payer-policy lookup, coverage routing, and speed from referral to actionable case.	Core coverage workflow. eBenefits Investigation runs across commercial and medical benefit; Patient Coverage Check provides automated real-time insurance view.
Prior authorization, appeals, and reimbursement casework	PA initiation, payer-specific forms, clinical documentation, appeals, denial management, and field reimbursement handoffs.	Core PA casework. SmartPA automates up to 90% of prior-authorization-requiring claims; confirm therapy-specific PA depth, appeals process, and field reimbursement handoff for specialty programs.
Affordability, PAP, and copay operations	Copay, free-drug, bridge, foundation, income verification, PAP renewal, and gross-to-net sensitive affordability logic.	Core affordability operations. 30+ years of patient assistance program administration is the operating heritage; high-volume copay and PAP transaction processing across 7 of the top 10 manufacturers.
Patient engagement and adherence operations	Omnichannel reminders, clinical education, nursing or training escalation, persistence outreach, and patient-facing support quality.	Engagement model. IntelliHealth supports modular patient access and HCP engagement; ask for nurse-led clinical infrastructure depth vs. transactional engagement.
Fulfillment, specialty pharmacy, and distribution coordination	Routing to SPs, non-commercial dispensing, DTP shipment, sample/replacement product, 3PL, and cold-chain handoffs.	Diligence area. Conduent coordinates handoffs rather than owning dispensing infrastructure; confirm SP routing, non-commercial dispensing partners, and cold-chain handoff design.
Program reporting, integrations, and governance	Manufacturer dashboards, KPI reporting, CRM/EHR/API integrations, SLA governance, and operating visibility across vendors.	Reporting layer. IntelliHealth cloud platform provides modular patient access, HCP engagement, and analytics; Microsoft Azure OpenAI Services collaboration announced 2024 for portfolio-wide innovation.

Buyer Fit

• Strongest fit: Evaluate Conduent for high-volume PAP administration, transactional copay processing, multilingual contact-center operations, and Medicaid PBM-adjacent claims work.
• Best-fit buyers: Pharma manufacturers running mature copay and PAP programs at scale; government and state Medicaid programs leveraging the federally certified Flexible Rx System; payers needing transactional BPO capacity.
• Less ideal fit: Specialty launches requiring purpose-built hub-services tech, integrated provider portals tied to specialty workflows, or vendors with a current digital-first product roadmap.
• Commercial fit: Per-transaction pricing fits the high-volume PAP and copay operating model; scope service levels, surge capacity, and per-program governance explicitly.
• Implementation diligence: Pharma-segment investment commitments and roadmap given parent-level financial distress; staffing model, launch-surge plan, data feeds into manufacturer CRM and analytics environments; SmartPA’s payer coverage by therapy area.

Differentiators

• 30+ years of PAP administration depth: Serving 7 of the top 10 pharma manufacturers; high-volume copay, PAP, foundation, and income-verification processing is the core operating muscle.
• IntelliHealth cloud platform: Modular patient access and HCP engagement; consolidates intake, BV, PA, copay, and analytics into one platform layer.
• Flexible Rx System (Medicaid PBM): First federally certified Medicaid pharmacy management platform (Montana, 2017); processes 454M+ claims/year across state Medicaid programs.
• SmartPA automation: Automates up to 90% of prior-authorization-requiring claims; differentiator vs. PA vendors that lean on manual casework.
• 100+ global locations and 20+ language support: Multilingual contact-center capacity supports broad therapy-area coverage and bilingual launch programs.

RFP Questions

• Which Conduent service line owns each step (intake, BV, PA, copay, PAP, adherence, reporting) in the proposed scope?
• What SmartPA payer coverage exists for the therapy areas in scope, and what is the actual end-to-end PA turnaround by payer?
• How is the IntelliHealth dashboard structured for manufacturer KPIs, audit trails, and downstream data delivery?
• What median time-to-therapy, PA turnaround, and first-fill conversion metrics can be reported by brand?
• How does Conduent integrate with specialty pharmacies, non-commercial dispensers, and 3PL partners for fulfillment handoffs?
• What pharma-segment investment, leadership, and product roadmap commitments are in place given parent-level financial distress?
• What launch-surge staffing, training, and bilingual coverage commitments are available in the first 90 days?

Recent Activity

• 2026-04 - Named a Leader in Everest Group’s 2026 Healthcare Payer Intelligent Operations PEAK Matrix Assessment.
• 2026-03 - Chief Information and Technology Officer Mark Prout departed.
• 2026-02 - Reported Q4 and full-year 2025 financial results; ongoing divestiture program continues to reshape the corporate portfolio.
• 2026-01 - Launched AI Experience Center to showcase AI and GenAI-powered solutions across Commercial, Transportation, and Government clients.
• 2024-06 - Repurchased all shares held by Carl Icahn and affiliates for approximately $132M, removing the activist shareholder.
• 2024-05 - Completed transfer of the BenefitWallet HSA portfolio to HealthEquity for $425M (three tranches).
• 2024 - Announced Microsoft Azure OpenAI Services collaboration for portfolio-wide innovation; Giles Goodburn appointed CEO succeeding Cliff Skelton.